Myoepithelial Carcinoma of the Breast Treated with Surgery and Chemotherapy
Author(s) -
Yumi WanifuchiEndo,
Hiroshi Sugiura,
Hiroko Yamashita,
Satoru Takahashi,
Nobuyasu Yoshimoto,
Mai Iwasa,
Tomoko Asano,
Tatsuya Toyama
Publication year - 2013
Publication title -
case reports in oncological medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.173
H-Index - 7
eISSN - 2090-6714
pISSN - 2090-6706
DOI - 10.1155/2013/164761
Subject(s) - medicine , myoepithelial cell , chemotherapy , breast carcinoma , radiation therapy , cyclophosphamide , metastasis , carcinoma , oncology , myoepithelioma , radiology , surgery , immunohistochemistry , breast cancer , cancer
Myoepithelial carcinoma (malignant myoepithelioma) of the breast is a rare tumor, for which only a limited number of reports have been published. Most of the reports emphasized diagnosis and pathology but not biological behavior and treatment. We report a 61-year-old patient with breast myoepithelial carcinoma who developed locoregional and distant metastases and received many chemotherapy regimens. She presented with an elastic hard mass of the left breast. Breast conserving surgery was performed as part of both diagnosis and treatment. From the results of histological and immunohistochemical examinations, this case was considered to be a myoepithelial carcinoma. Fifteen months after the completion of adjuvant radiotherapy, distant metastasis of the left parasternal lymph node metastasis developed. She was treated by further excision and received a total of four regimens of chemotherapy including a combination of doxorubicin and cyclophosphamide. She received chemotherapy for 20 months after the diagnosis of metastasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom